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Abstract 
A male patient with retinitis pigmentosa (RP) accompanied by repeated vitreous 
hemorrhage in both eyes underwent unilateral vitrectomy. Visual acuity recovered to 0.8 
in the operated right eye, and no hemorrhage, complications or progression of RP were 
observed. Fluorescein angiography performed 2 months after surgery detected 
neovascularization at the optic disc in the operated right eye, but not in the non-
operated left eye, and no avascular areas were found in either eye. Vitrectomy may be 
effective for the treatment of RP accompanied by vitreous hemorrhage. 
 
Introduction 
Cataract, glaucoma, cystoid macular edema, and macular hole are complications of 
retinitis pigmentosa (RP). RP can also be accompanied by vitreous hemorrhage [1–4], 
albeit more rarely. Here, we report a case of RP with repeated vitreous hemorrhage for 
which we performed vitrectomy. 
Case Presentation 
A 27-year-old male, who had been first diagnosed with RP at the age of 8 years, was being routinely 
followed. He presented with concentric visual field constriction to 10° and flattening of the waves on 
electroretinograms. His father had a history of RP. The patient suffered from vitreous hemorrhage at the 
age of 19, and although the bleeding spontaneously resolved in around 1 month with an improvement 
in vision, he was routinely followed up. Since the first hemorrhage, vitreous hemorrhage has recurred 
numerous times followed by spontaneous recovery in around 1 month. 
In May 2010, vitreous hemorrhage recurred in the patient’s right eye and the bleeding was extensive. 
Because no improvement was seen after 1 month, the patient was referred to the Department of 
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The initial medical examination at our hospital revealed that visual acuity of the right eye was hand 
movements and for the left eye it was 1.2 × –2.75D cyl –3.00DA × 180°. Intraocular pressure was 14 mm 
Hg in the right eye and 16 mm Hg in the left eye. Because vitreous hemorrhage in the right eye showed 
no improvement at the 1-month follow-up observation, we performed a 23-gauge vitrectomy on July 27, 
2010. During surgery, intraocular endoillumination as well as microscope illumination were set as low 
as possible, and the infusion pressure was set at 25 mm Hg (fig. 1). Dense hemorrhage and adhesion of 
the optic disc and the vitreous body were observed. Posterior vitreous detachment was present in other 
areas. Bone spicule-like pigmentation and blood vessel constriction were remarkable in the ocular 
fundus from the vascular arcades to the equator, with no proliferative changes. The lens was preserved, 
and the vitreous body around the port was removed by compressing the sclera. Operation time was 40 
min. After surgery, visual acuity of the right eye recovered to 0.8 × –3.25D cyl – 3.25DA × 10°, and no 
postoperative complications were observed. 
Fig. 2 shows the results of fluorescein angiography (FA) performed 2 months after surgery. In both 
eyes, we observed atrophy of the pigment epithelium except in the macula, constriction of retinal 
vessels, appearance of pigmentation, and minor vascular leakage. In the right eye, we observed atrophy 
of the choroidal capillary plate seen below the optic disc. In the late phase, neovascularization was 
observed over the optic disc, which was thought to be the cause of the previous vitreous hemorrhage. In 
the left eye, there were no findings of neovascularization or anything that might cause bleeding. No 
avascular areas were present in either eye.  
Kinetic visual field testing performed 3 months after surgery revealed no postoperative changes in 
the visual field (fig. 3). 
In the right eye, neither recurrence of vitreous hemorrhage nor change in the neovascular vessels 
over the optic disc has been observed for 10 months after surgery. Although the left eye has shown 
repeated vitreous hemorrhage, the blood usually absorbs without treatment in around 1 month; 
therefore, the left eye is currently under observation. 
Discussion 
Various complications of RP have been reported, and cases of vitreous hemorrhage 
accompanying RP are occasionally encountered. Neovascularization, retinal vascular 
abnormalities [1–4], and Coats’-like exudative retinal detachment [5–7] are the 
mechanisms reportedly associated with vitreous hemorrhage in RP.  
In the present case, FA detected neovasculature over the optic disc, but no avascular 
areas, in the right eye after surgery. In chronic inflammatory diseases, neovascularization 
is occasionally seen in absence of non-perfused areas [8]. In our RP case, the patient had 
suffered persistent chronic inflammation, and inflammatory cells were at times detected 
in the vitreous body, both of which might have led to the formation of the neovasculature. 
Similar to the right eye, the left eye has repeatedly shown vitreous hemorrhage. 
However, FA did not detect any non-perfused areas or neovascularization, and thus the 
cause of the hemorrhage is currently unknown. A lesion may be present in the extreme 
periphery of the retina, the area not covered by FA, or it is possible that a pathological 
condition is present which cannot be detected by FA. Nao-i et al. [4] reported FA findings 
of neovascular and surrounding avascular formation in a case of vitreous hemorrhage 
presenting 2 years after no initial findings of neovascularization or avascular areas had 
been seen on FA. For this reason, we will continue with the careful observation of the 
patient and provide treatment if the formation of neovascular or avascular areas appears. 
Potential treatments for vitreous hemorrhage accompanying RP include 
photocoagulation, intravitreal injection of the anti-vascular endothelial growth factor 
(VEGF), and vitrectomy combined with regular follow-up observations. Anti-VEGF Case Rep Ophthalmol 2011;2:256–261 
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treatment is considered useful for regression of the neovasculature when hemorrhage is 
caused by neovascularization. However, some questions remain as to whether anti-VEGF 
treatment presents no problem for RP.  
In the present case of vitreous hemorrhage, surgery was performed because the patient 
suffered frequent recurrence, and the last episode of bleeding was not resolved within 2 
months. There are, however, cases where vitreous hemorrhage improves after long-term 
follow-up observation with no recurrence of bleeding [1, 2, 4–7]. Therefore, at the time of 
first bleeding, it is necessary to consider the potential adverse effects of vitrectomy on the 
progression of RP and decide the length of the follow-up observation.  
There are reports of vitrectomy performed on patients with macular disease, such as 
macular hole and macular edema [9, 10], accompanying RP, which led to a reduction in 
the amplitude of the multifocal electroretinogram and decreased visual acuity after 
surgery. On the other hand, Hayashi et al. [3] performed vitrectomy in a case of vitreous 
hemorrhage without any postoperative complications or RP progression. Similarly, in the 
present case, there has been no noticeable progression of RP during the 10 months of 
follow-up after surgery. Kinetic visual field testing performed 3 months after surgery also 
revealed no postoperative changes in the visual field (fig. 3). However, the indication for 
vitrectomy in RP needs to be determined carefully, provided that there are no other 
complications besides vitreous hemorrhage, as in the present case, and that surgery is 
performed with surgical stress such as damage from endoillumination and infusion 
pressure minimized, it appears that vitrectomy can be an effective treatment for vitreous 
hemorrhage in RP. 
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Fig. 1. During vitrectomy, intraocular endoillumination was set as low as possible. 
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Fig. 2. a Fundus photograph. b FA performed 2 months after vitrectomy. In the right eye, 
neovascularization was observed over the optic disc (black arrowhead). 
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Fig. 3. Kinetic visual field testing performed 3 months after surgery revealed no postoperative changes 
in the visual field. a Before vitrectomy. b Three months after vitrectomy. 
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